Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) With or Without Ribavirin for Participants With Hepatitis C Genotype 1, 4, or 6 Infections Who Have Failed Prior Treatment With Pegylated Interferon + Ribavirin (MK-5172-068)
Clinical trial NCT02105701 · COMPLETED
Trial details
- NCT number
- NCT02105701
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-05
- Primary completion
- 2015-03-24
- Enrollment
- 420
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.